Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,351.70
+47.00 (3.60%)
Jul 13, 2026, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 141.41 billion as of July 13, 2026. Its market cap has decreased by -26.43% in one year.
Market Cap
141.41B
Enterprise Value
137.26B
Revenue
10.55B
Ranking
n/a
PE Ratio
54.37
Stock Price
1,351.70
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 141.41B, an increase of 43.37%. That is a compound annual growth rate of 13.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 141.41B | 0.45% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 677.29B |
| Anthem Biosciences | 425.04B |
| OneSource Specialty Pharma | 186.52B |
| Blue Jet Healthcare | 108.25B |
| Supriya Lifescience | 68.78B |
| Zota Health Care | 49.28B |
| Panacea Biotec | 33.48B |
| Dishman Carbogen Amcis | 30.71B |